EUVIMEDEUVIMED entdecken
Open Access

PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)

E M D Smith, A Aggarwal, J Ainsworth, E Al-Abadi, T Avcin, L Bortey, J Burnham, C Ciurtin, C M Hedrich, S Kamphuis, L Lambert, D M Levy und 13 weitere

Clinical Immunology · 2023-05 · 250 · 109296

DOI: 10.1016/j.clim.2023.109296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2023-05. Verfasst von E M D Smith und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; Department of Paedi…. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Versus Arthritis, Department of Health, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To achieve a consensus-based definition of Low Disease Activity (LDA) for use in cSLE trials. METHODS: The International cSLE T2T Task Force, comprising of paediatric rheumatologists/nephrologists, and adult rheumatologists undertook a series of Delphi surveys/consensus meetings to discuss, refine, and vote upon cSLE LDA criteria. RESULTS: The Task Force agreed that LDA should be based upon the adult-SLE Lupus Low Disease Activity State definition (LLDAS), with modifications to make it applicable to cSLE (cLLDAS). They agreed upon five cLLDAS criteria: (1) SLE Disease Activity Index (SLEDAI)-2 K ≤4, with no activity in major organ systems; (2) no new features of lupus disease activity compared with the last assessment; (3) Physician Global Assessment score of ≤1 (0-3 scale); (4) prednisolone dose of ≤0.15 mg/kg/day, 7.5 mg/day/maximum; while on (5) stable antimalarials, immunosuppressives, and biologics. CONCLUSIONS: A cSLE-appropriate definition of cLLDAS has been generated, maintaining alignment with the adult-SLE definition to promote life-course research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsLupus Erythematosus, SystemicAdultChildHumansSeverity of Illness IndexPrednisoloneConsensus

Stichwörter der Autor:innen

Childhood-SLELow disease activityT2TTreat-to-targetcLLDAScSLE

Substanzen

Immunosuppressive AgentsPrednisolone

Autor:innen und Institutionen

  • Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpo…
  • Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Department of Paediatric Rheumatology, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
  • Department of Allergology, Rheumatology and Clinical Immunology, Children's Hospital, University Medical Center Ljubljana, Slovenia.
  • TARGET Lupus Public Patient Involvement and Engagement Group, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Department of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, USA.

Förderung

  • Versus Arthritis
  • Department of Health
  • Intramural NIH HHS
  • Wellcome Trust
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute for Social Care and Health Research
  • National Institute for Health and Care Research
  • University of Liverpool

Zitieren

APA

Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., Burnham, J., Ciurtin, C., Hedrich, C. M., Kamphuis, S., Lambert, L., Levy, D. M., Lewandowski, L., Maxwell, N., Morand, E., Ozen, S., Pain, C. E., Ravelli, A., Saad Magalhaes, C., …, & International cSLE T2T Task Force (2023). PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). Clinical Immunology, 250, 109296. https://doi.org/10.1016/j.clim.2023.109296

Vancouver

Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, et al. PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). Clinical Immunology. 2023;250:109296. doi:10.1016/j.clim.2023.109296

BibTeX
@article{Smith2023,
  author = {Smith, E M D and Aggarwal, A and Ainsworth, J and Al-Abadi, E and Avcin, T and Bortey, L and Burnham, J and Ciurtin, C and Hedrich, C M and Kamphuis, S and Lambert, L and Levy, D M and Lewandowski, L and Maxwell, N and Morand, E and Ozen, S and Pain, C E and Ravelli, A and Saad Magalhaes, C and Pilkington, C and Schonenberg-Meinema, D and Scott, C and Tullus, K and Beresford, M W and International cSLE T2T Task Force, International cSLE T2T Task Force},
  title = {PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)},
  journal = {Clinical Immunology},
  year = {2023},
  volume = {250},
  pages = {109296},
  doi = {10.1016/j.clim.2023.109296}
}
Kostenlos starten →